baber/WOPTO huggingface dataset:
Patent DE-69322353-D1 (DE)
Inventor: BRION JEAN-DANIEL
IPC: A61K31/66
Filed: 1993-09-29
Granted: 1999-01-14
Abstract: Compounds of general formula (I): <IMAGE>  in which the R1 to R8 groups are as defined in the description. Medicaments.
Patent DE-69325864-D1 (DE)
Inventor: MORELLI PETER ALAN
IPC: F16D1/08
Filed: 1993-06-04
Granted: 1999-09-09
Abstract: A shaft (44,144,145) is conventionally driveably connected to a bore (46,146) by a steel key of rectangular cross-section. Where the shaft is of smaller diameter than the bore, a slotted nylon sleeve is fitted between them and a tall steel key extends through the slot. Failure of both standard and tall keys can occur for various reasons. A unitary component (50,162,163) of suitable plastics material or non-ferrous metal is therefore proposed. This component essentially includes an integral key (56,174) of curved cross-section adapted to engage in a mating keyway (176) formed in the bore. Where the shaft (44) and bore (46) are nominally of the same diameter, the component (50) consists also of an integral key (52) of rectangular cross-section adapted to engage in the conventional keyway (48) in the shaft. Where the shaft (144,145) is of smaller diameter than the bore (146), the component (162,163) also includes a sleeve (164) with the key (174) of curved cross-section formed on its outer periphery, and a keyway (170) of rectangular cross-section formed in its inner periphery and adapted to be driveably connected by a separate standard key (171) to the conventional keyway (148,149) in the shaft. The component is useful in the flange-mounting of different electric motors on off-the-shelf gear units. <IMAGE>
Patent DE-69400213-D1 (DE)
Inventor: STEPHENS BARRY D
IPC: E01F15/14
Filed: 1994-01-27
Granted: 1996-07-04
Abstract: The crash cushion comprises a number of panels positioned to overlap one another partially along an anticipated impact direction. There is a mechanical linkage coupled to the panels to suspend the panels above grade adjacent a wall such that the panels are oriented parallel to the wall and the panels are movable toward the wall. The linkage comprises a number of support struts each pivoted at a first end adjacent the wall and at a second end adjacent a respective panel. There are energy absorbing elements positioned adjacent the panels between the panels and the wall and suspended above grade at least in part by the linkage such that movement of the panels toward the wall deforms the energy absorbing elements, thereby retarding movement of the panels toward the wall.
Patent DE-69401901-D1 (DE)
Inventor: BAILLOD FREDERIC
IPC: F41H13/00
Filed: 1994-10-20
Granted: 1997-04-10
Abstract: It comprises a propulsion unit and a projectile comprising a cylindrical body (6) pierced with a central channel (8), at the end of which an explosive charge (7) is located, this body being equipped with receptacles (9, 9'), in which come to bear balls (10, 10') connected to the body (6) by means of flexible ties (12, 12'). The propulsion unit consists of a case (3) containing powder (3) and a primer (2). <IMAGE>
Patent DE-69411146-D1 (DE)
Inventor: CLOOS PETER
IPC: C08L101/12
Filed: 1994-01-07
Granted: 1998-07-23
Abstract: It has been found that fibres can be spun in a simple manner from polyketone polymer solutions by making a thermoreversible gel from a solution of polyketone and a solvent for the polymer having a boiling temperature above 443 K, a melting temperature below 373 K, and a polymer dissolving temperature above 443 K. The thermoreversible gel forms as the solution is cooled. Because of the specific properties of the solvent in combination with the concentration of the polymer and its intrinsic viscosity, a permanently orientable thermoreversible gel is formed by cooling. The polymer crystallises on being cooled, optionally while still in the presence of the solvent. Preferably, so much polymer is dissolved as will give a product of the polymer concentration and [ eta ]<0,5> (wherein [ eta ] represents the intrinsic viscosity of the polymer) of higher than 0,35 (dl/g)<0,5>.
Patent DE-69413018-D1 (DE)
Inventor: HENDRY NEIL GEDDES CLARKSON
IPC: C07D307/32
Filed: 1994-03-22
Granted: 1998-10-08
Abstract: PCT No. PCT/GB95/00579 Sec. 371 Date Apr. 4, 1996 Sec. 102(e) Date Apr. 4, 1996 PCT Filed Mar. 22, 1994 PCT Pub. No. WO94/22849 PCT Pub. Date Oct. 13, 1994Compounds having utility in medicine in countering cellular malfunction e.g. in conditions embraced by the general term "cancer", which compounds normally exist us a keto-enol tautomeric pair, the racetalc keto form of which is rapresented by formula (Ia), wherein R is a hydrogen, lower alkyl, acyl, or another functional group of up to 6 carbons including at least one hetero atom, which atom may be directly bonded to the  beta -carbon, which compound may be in the acylic form shown or in a cyclic form as equilibrium keto-enol tautomer derivatives and anomeric forms thereof, including enantiomers when R is hydrogen and diastereoisomers when R is another group. A method of obtaining such a compound comprises selecting an appropriate dihydrofuran having a protected primary alcohol side chain in the 2-position, subjecting the said protected alcohol side chain-substituted dihydrofuran to oxidation using a chromium-based reagent to yield the corresponding acid, subjecting said acid to iodolaetonisation conditions to yield the cis,cis,trans-trisubstituted iodo-lactone which upon displacement of the iodine provides the cis,cis,cis-tri-substituted hydroxylacetone which is capable of being reduced to obtain a lactol which is in equilibrium with the corresponding open chain aldehyde.
Patent DE-69428312-D1 (DE)
Inventor: HARVEY WILSON
IPC: A61L31/00
Filed: 1994-07-27
Granted: 2001-10-25
Abstract: Absorbable composite materials are described that comprise a collagen matrix reinforced with a layer of a bioabsorbable polymer. A chemotherapeutic agent is dispersed in the composite material. The layer of bioabsorbable polymer is preferably a woven, nonwoven or knitted mesh layer of a synthetic bioabsorbable polymer such as polylactic/polyglycolic acid copolymer, or oxidised regenerated cellulose. The chemotherapeutic agent may be an antibiotic, an anaesthetic, an antiseptic or an anti-inflammatory. Strips of the composite material are inserted into the periodontal pocket, where they are retained in place and provide effective sustained release of the chemotherapeutic agent over an extended period.
Patent DE-69429433-D1 (DE)
Inventor: SANCOFF E
IPC: B01J7/02
Filed: 1994-08-08
Granted: 2002-01-24
Abstract: A device is disclosed which provides direct and effective incorporation of material (such as medicine) from a separate container into the contents of a liquid dispensing device. The device has a hollow sleeve extending outwardly, an openable closure, a securing member which engages a mating member on the container, and a conduit (such as a needle) to provide fluid communication between the device and the container, with the fluid communication occurring upon attachment of the container to the device. The device can also provide for attaching the separate container to the dispensing device but without initially establishing liquid communication between the two.
Patent DE-69432739-D1 (DE)
Inventor: PONROY YVES
IPC: A23L33/15
Filed: 1994-12-08
Granted: 2003-07-03
Abstract: The present invention relates to the food field, and more especially to the field of nutritional supplements for the feeding of delicate or undernourished subjects. It relates more especially to food compositions intended for premature infants or those of low weight, which contain mammalian brain phospholipids as a physiological source of polyunsaturated fatty acids of the n-3 series, in combination or mixed with a food carrier for the feeding of very young infants. The invention also relates to a process for obtaining mammalian brain phospholipids. Use in dietetics.
Patent DE-69433578-D1 (DE)
Inventor: ZUCKERMAN STEVEN HAROLD
IPC: A61K31/445
Filed: 1994-12-19
Granted: 2004-04-01
Abstract: The use of a compound having the formula <CHEM>  wherein R<1> and R<3> are independently hydrogen, <CHEM>  or <CHEM>  wherein Ar is optionally substituted phenyl; R<2> is selected-from the group consisting of pyrrolidino and piperidino; or a pharmaceutically acceptable salt or solvate thereof, in the preparation of a medicament useful for inhibiting LDL oxidation.
Patent DE-69434403-D1 (DE)
Inventor: CARLINO JOSEPH A
IPC: A61P31/04
Filed: 1994-09-20
Granted: 2005-07-14
Abstract: The present invention is concerned with the use of a complex comprising an insulin-like growth factor (IGF) and insulin-like growth factor binding protein-3 (IGFBP-3) for the manufacture of a medicament for the treatment of an immune system disorder. The present invention is also concerned with the use of insulin-like growth factor binding protein-3 (IGFBP-3) in the manufacture of a medicament for treating an IGF-driven lymphoproliferative condition.
Patent DE-69503705-D1 (DE)
Inventor: FAELLDIN AGNE
IPC: H02J3/01
Filed: 1995-05-19
Granted: 1998-09-03
Abstract: The invention relates to an interference suppression method and circuit for an electrical system, said electrical system comprising a main transformer (2) with a star point (12), phase leg conductors (L1, L2, L3) connected to the transformer (2), a neutral conductor (N) connected to the earth potential (3) and to the star point (12) of the transformer (2), and loads (5) connected between the phase leg conductors (L1, L2, L3) and the neutral conductor (N), said loads being connected to the neutral conductor (N) at connection points (4). in accordance with the invention a bandstop filter (1) tuned at a center frequency 3*f is connected between the star point (12) of the transformer (2) and the connection points (4) of the loads (5). <IMAGE>
Patent DE-69515343-D1 (DE)
Inventor: VAN GESTEL WILHELMUS JACOBUS
IPC: H04N9/804
Filed: 1995-03-29
Granted: 2000-04-06
Abstract: A recording arrangement is provided for recording trick mode information in portions of tracks, so as to enable a trick mode during reproduction in a reproducing arrangement. The recording arrangement comprises an input terminal (11) for receiving the digital video signal, a trick play signal generating unit (80) for deriving a trick play signal from the digital video signal, and an error correction encoding unit (26,28,81). The error correction encoding unit is adapted to carry out an error correction encoding step on the digital video signal and the trick play signal, such that an additional error correction encoding step is carried out on the trick play data. <IMAGE>   <IMAGE>
Patent DE-69521611-D1 (DE)
Inventor: BACKLUND SUNE
IPC: A61K47/36
Filed: 1995-04-28
Granted: 2001-08-09
Abstract: PCT No. PCT/FI95/00234 Sec. 371 Date Nov. 12, 1997 Sec. 102(e) Date Nov. 12, 1997 PCT Filed Apr. 28, 1995 PCT Pub. No. WO95/31969 PCT Pub. Date Nov. 30, 1995A pharmaceutical composition containing a microemulsion made up of a hydrophilic component, a lipophilic component, a surfactant and a drug, where the hydrophilic component, the lipophilic component and the surfactant form, when examined on a macroscopic scale, a one-phase solution. The hydrophilic component is dispersed as colloidal droplets in the lipophilic component, or the lipophilic component is dispersed as colloidal droplets in the hydrophilic component. According to still another alternative, the hydrophilic and the lipophilic components form a microemulsion with bicontinuous structure where the components form elongated adjacent channels. The drug is dissolved in the dispersed component or, in the case of a microemulsion with bicontinuous structure, in the hydrophilic or the lipophilic component. The microemulsion is stabilized by means of the surfactant. It is characteristic that a gelatinizer and water are added to the microemulsion thereby bringing the microemulsion into a gel form.
Patent DE-69528874-D1 (DE)
Inventor: RUBIANES JOSE MANUEL
IPC: C21D9/48
Filed: 1995-08-22
Granted: 2003-01-02
Abstract: Mild steel sheet is made by hot rolling slab into sheet followed by cold rolling the sheet. The cold rolled sheet is then subjected to a first anneal in which the steel is recrystallised and the carbon passed into solid soln.. The recrystallisation temp. is held for a while to enable some over-ageing and the amt. of carbon dissolved in the soln. exceeds a predetermined value. The sheet is then subjected to a second anneal at a low temp. which precipitates some of the carbon in soln.. Finally, the sheet is subjected to a skin passing operation.
Patent DE-69533942-D1 (DE)
Inventor: COOK DAVID
IPC: A61K35/16
Filed: 1995-11-08
Granted: 2005-02-24
Abstract: Methods and compositions for treating pathogens in material are described, including methods of decontaminating human fluids prior to processing in the clinical laboratory and methods for decontaminating blood products prior to in vivo use. The techniques handle large volumes of human serum without impairing the testing results. Novel compounds for photodecontaminating biological material are also contemplated which are compatible with clinical testing, in that they do not interfere with serum analytes.
Patent DE-69535130-D1 (DE)
Inventor: PARKER L
IPC: G02B1/04
Filed: 1995-11-04
Granted: 2006-09-07
Abstract: Plastic lenses are provided wherein a tinting agent is provided within the coating to impart color to the lens. Methods are provided whereby such coatings can be applied to plastic lenses using radiation or thermal curing techniques with a plastic coating.
Patent DE-69601463-D1 (DE)
Inventor: SIMOENS HERVE
IPC: F27D3/16
Filed: 1996-04-17
Granted: 1999-03-11
Abstract: PCT No. PCT/FR96/00581 Sec. 371 Date Feb. 2, 1998 Sec. 102(e) Date Feb. 2, 1998 PCT Filed Apr. 17, 1996 PCT Pub. No. WO96/33380 PCT Pub. Date Oct. 24, 1996The invention concerns a process for fitting a gas-injecting nozzle in the wall of an installation. The process is characterized in that an external supporting surface (11) whose shape matches the so-called internal supporting surface (12) of the passage (6) provided in the bedding brick is associated with the nozzle (2); the nozzle is placed opposite the passage (6) in the bedding brick: the nozzle (2) is moved in axial translation so as to adjust the position thereof along the longitudinal axis of the passage and move the front face of the nozzle into a desired initial position; the nozzle is locked in this desired initial position; and, at least periodically, the nozzle is inserted further forwards into the passage in the bedding brick in order to compensate the wear in the front face of the nozzle. The invention can be used to prevent clogging, such as in a cement producing plant.
Patent DE-69608252-D1 (DE)
Inventor: VILLEMOES HANS
IPC: G01J3/02
Filed: 1996-02-09
Granted: 2000-06-15
Abstract: PCT No. PCT/DK96/00068 Sec. 371 Date Apr. 3, 1996 Sec. 102(e) Date Apr. 3, 1996 PCT Filed Feb. 9, 1996 PCT Pub. No. WO96/24832 PCT Pub. Date Aug. 15, 1996A method for standardizing a spectrometer generating an optical spectrum from a sample, comprising generating at least one optical spectrum from at least one standardization sample each having a chemical composition resulting in the optical spectrum showing a characteristic pattern in a predetermined frequency range, comparing information relating to the pattern(s) to corresponding information relating to at least one reference pattern previously defined as the desired standard response from the at least one standardization sample, determining, based on the comparison, standardizing parameters describing the transition of the pattern(s) of the generated spectrum or spectra to the reference pattern(s) and storing said standardizing parameters in the spectrometer or a computer connected thereto, so that the spectrometer, when presented to an unknown sample, will, using the standardization parameters, generate an optical spectrum substantially identical to that which would be generated in a corresponding spectrometer standardized with a sample of the same chemical composition using the same previously defined reference pattern(s). The present method relates to standardization of the instrument to a well-defined state into which any number of instruments may be brought. In this state, calibrations may be transferred freely from instrument to instrument.
Patent DE-69614129-D1 (DE)
Inventor: ROINE JOHANNES
IPC: G01N21/73
Filed: 1996-10-10
Granted: 2001-08-30
Abstract: PCT No. PCT/FI96/00535 Sec. 371 Date Aug. 14, 1998 Sec. 102(e) Date Aug. 14, 1998 PCT Filed Oct. 10, 1996 PCT Pub. No. WO97/14278 PCT Pub. Date Apr. 17, 1997The present invention relates to a procedure and a device for forming a plasma. The plasma generated can be used e.g. to examine the concentrations of elements contained e.g. in different gases, such as flue gases. The spark discharge and magnetic field used to form and maintain the plasma are produced by means of the same capacitor-coil resonator circuit. The device of the invention allows a very stable and controlled plasma to be achieved.
Patent DE-69616303-D1 (DE)
Inventor: BURKE R
IPC: C07C237/00
Filed: 1996-03-29
Granted: 2001-11-29
Abstract: The present invention relates to non-phosphorus containing O-malonyltyrosyl compounds, derivatives thereof, uses of the O-malonyltyrosyl compounds in the synthesis of peptides, and O-malonyltyrosyl compound-containing peptides. The O-malonyltyrosyl malonyltyrosyl compounds and O-malonyltyrosyl compound-containing peptides of the present invention are uniquely stable to phosphotases, capable of crossing cell membranes, suitable for application to peptide synthesis of O-malonyltyrosyl compound-containing peptides, and amenable to prodrag derivatization for delivery into cells. The present invention also provides for O-malonyltyrosyl compound-containing peptides which exhibit inhibitory potency against binding interactions of receptor domains with phosphotyrosyl-containing peptide ligands.
Patent DE-69634254-D1 (DE)
Inventor: BROWN ROBERT
IPC: A61K31/55
Filed: 1996-08-14
Granted: 2005-03-03
Abstract: PCT No. PCT/GB96/01985 Sec. 371 Date Feb. 13, 1998 Sec. 102(e) Date Feb. 13, 1998 PCT Filed Aug. 14, 1996 PCT Pub. No. WO97/06802 PCT Pub. Date Feb. 27, 1997A compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein G, T1, T2 and T3 are selected from CH and N; provided that T2 and T3 are not both CH; A is selected from a direct bond and (1-4C)alkylene; X is selected from oxy, thio, sulphinyl, sulphonyl, carbonyl, carbonylamino, N-di-(1-6C)alkylcarbonylamino, sulphonamido, methylene, (1-4C)alkylmethylene and di-(1-6C)alkylmethylene, and when T2 is CH, X may also be selected from aminosulphonyl and oxycarbonyl; and Q is selected from (5-7C)cycloalkyl, a heterocyclic moiety containing up to 4 heteroatoms selected from nitrogen, oxygen and sulphur, phenyl, naphthyl, phenyl(1-4C)alkyl and phenyl(2-6C)alkenyl; for the manufacture of a medicament for treating diseases or medical conditions in which an inhibition of oxido-squalene cyclase is desirable.
Patent DE-69701264-D1 (DE)
Inventor: BOSATELLI DOMENICO
IPC: H01H71/10
Filed: 1997-07-15
Granted: 2000-03-09
Abstract: A kinematic device for actuating the moving contact, particularly for automatic electric breakers, includes inside a box-like body, a motion lever (2) which is connected to a lever (10) for actuating the breaker and is pivoted to the box-like body by means of a first pivot (3). The motion lever (2) is articulated to linkages (11) which are pivoted, at the other end, to the first end (12) of a cross-member (13) which is operatively associated with a moving contact (15). The first end (12) of the cross-member (13) slidingly engages an engagement lever (21) which is pivoted to the box-like body by means of a second pivot (22) and is provided with a locking arm (30) of a control part (31) which is pivoted to the box-like body by means of a third pivot (32). The third pivot (32) constitutes the fulcrum of the moving contact (15).
Patent DE-69707865-D1 (DE)
Inventor: O'BRIEN MICHAEL
IPC: A61K31/00
Filed: 1997-04-24
Granted: 2001-12-06
Abstract: Compounds of formula (I) wherein R<1> includes alkyl, halo, nitro, amino, cyano, alkoxy, and alkoxycarbonyl; R<2> is alkyl and substituted alkyl; and R<3> is OH or NHOH, are useful for inhibiting matrix metalloproteinase enzymes in animals, and as such, prevent and treat diseases resulting from the breakdown of connective tissues.
Patent DE-69711642-D1 (DE)
Inventor: JOLLY ANDRE JEAN
IPC: H01R4/24
Filed: 1997-08-20
Granted: 2002-05-08
Abstract: PCT No. PCT/FR97/01508 Sec. 371 Date Mar. 30, 1999 Sec. 102(e) Date Mar. 30, 1999 PCT Filed Aug. 20, 1997 PCT Pub. No. WO98/08271 PCT Pub. Date Feb. 26, 1998A sandwich panel with conductive cores (10,12) interposed between layers (14,16,18) of foam insulating material, particularly of polyurethane, supporting elements (22) provided with at least one pin (26) for connection to the cores, particularly lamps (24) supplied with electrical energy by these cores connected to a source of current, characterized in that the insulating foam material has an elasticity threshold at least equal to the maximum pressure exerted by one of the pins of an element (22) inserted in the foam.
Patent DE-69717791-D1 (DE)
Inventor: FARMER W
IPC: C01B31/08
Filed: 1997-02-06
Granted: 2003-01-23
Abstract: Treatment of a wet activated carbon with carbon dioxide or with carbon dioxide followed by air results in a carbon having a reduced contact pH. The activated carbon is characterized by a modified contact pH less than about 9.0 and typically between about 7.3 and 9.0. Use of this carbon in a water treatment system eliminates the excessive effluent water pH rise which commonly occurs with activated carbon. Also use of this carbon in a water treatment system reduces the aluminum concentration of the water when compared to an untreated carbon.
Patent DE-69720514-D1 (DE)
Inventor: ARCOS JIMENEZ ANTONIO
IPC: C12P19/02
Filed: 1997-10-01
Granted: 2003-05-08
Abstract: The process refers to highly selective enzymatic production of monosaccharides and mono- polyols and/or disubstitued with fatty acids. The procedure is based on the simple mixture of polyol or monosaccharide with the fatty acid, the addition of solvent, and the use of lipases that permit the highly selective obtainment of these products without catalysts or toxic agents. The water produced during the process must be continuously removed throughout the same. The invention belongs to the alimentary, pharmaceutical, cosmetic and chemical sectors. The products obtained are excellent biodegradable and biocompatible non-ionic tensioactive agents which are used as additives for their emulsifying, oily, thickening and moisturising properties.
Patent DE-69721325-D1 (DE)
Inventor: OHLSON KURT LENNART
IPC: A45F5/02
Filed: 1997-05-13
Granted: 2003-05-28
Abstract: PCT No. PCT/SE97/00779 Sec. 371 Date Nov. 12, 1998 Sec. 102(e) Date Nov. 12, 1998 PCT Filed May 13, 1997 PCT Pub. No. WO97/42847 PCT Pub. Date Nov. 20, 1997The present invention relates to a card holder arrangement for holding a card that contains specific information and that has specific dimensions. The card holder comprises a rectangular or generally rectangular base plate, raised first side-edges extending along respective long sides of said base plate, raised second side-edges extending along respective short sides of the base plate, a projection on each of the raised first side-edges, said projections extending in over the base plate and towards each other from that edge surface of respective first side-edges which face away from the base plate. The raised second side-edges and the short sides of the base plate include recesses that enable a card placed in said card holder to be gripped on each short side of the card holder, these recesses dividing the raised second side-edges into two laterally related part-edges. The arrangement also includes means for preventing a magnetic strip on a card from becoming worn as a result of inserting and removing the card into and out of the card holder. These means include a beveled surface on respective part-edges that face away from the base plate and slope towards the base plate and towards the recess.